BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20418093)

  • 1. Genome-wide association studies in common cancers--what have we learnt?
    Varghese JS; Easton DF
    Curr Opin Genet Dev; 2010 Jun; 20(3):201-9. PubMed ID: 20418093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
    Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
    Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association studies in cancer.
    Easton DF; Eeles RA
    Hum Mol Genet; 2008 Oct; 17(R2):R109-15. PubMed ID: 18852198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.
    Cox DG; Curtit E; Romieu G; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Deleuze JF; Pauporté I; Thomas G; Pivot X
    Oncotarget; 2016 Nov; 7(47):77358-77364. PubMed ID: 27764800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries.
    Park JH; Wacholder S; Gail MH; Peters U; Jacobs KB; Chanock SJ; Chatterjee N
    Nat Genet; 2010 Jul; 42(7):570-5. PubMed ID: 20562874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues.
    Chen H; Kichaev G; Bien SA; MacDonald JW; Wang L; Bammler TK; Auer P; Pasaniuc B; Lindström S
    Hum Genet; 2019 Oct; 138(10):1091-1104. PubMed ID: 31230194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new genetic risk factors for prostate cancer.
    Guy M; Kote-Jarai Z; Giles GG; Al Olama AA; Jugurnauth SK; Mulholland S; Leongamornlert DA; Edwards SM; Morrison J; Field HI; Southey MC; Severi G; Donovan JL; Hamdy FC; Dearnaley DP; Muir KR; Smith C; Bagnato M; Ardern-Jones AT; Hall AL; O'Brien LT; Gehr-Swain BN; Wilkinson RA; Cox A; Lewis S; Brown PM; Jhavar SG; Tymrakiewicz M; Lophatananon A; Bryant SL; ; ; ; Horwich A; Huddart RA; Khoo VS; Parker CC; Woodhouse CJ; Thompson A; Christmas T; Ogden C; Fisher C; Jameson C; Cooper CS; English DR; Hopper JL; Neal DE; Easton DF; Eeles RA
    Asian J Androl; 2009 Jan; 11(1):49-55. PubMed ID: 19050691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-GWAS in prostate cancer: from genetic association to biological contribution.
    Farashi S; Kryza T; Clements J; Batra J
    Nat Rev Cancer; 2019 Jan; 19(1):46-59. PubMed ID: 30538273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Study Confirmed Three Breast Cancer-Specific Molecular Subtype-Associated Susceptibility Loci in Chinese Han Women.
    Xu Y; Chen M; Liu C; Zhang X; Li W; Cheng H; Zhu J; Zhang M; Chen Z; Zhang B
    Oncologist; 2017 Aug; 22(8):890-894. PubMed ID: 28408616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.
    Chang BL; Cramer SD; Wiklund F; Isaacs SD; Stevens VL; Sun J; Smith S; Pruett K; Romero LM; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Adolfsson J; Liu W; Kim JW; Duggan D; Carpten J; Zheng SL; Rodriguez C; Isaacs WB; Grönberg H; Xu J
    Hum Mol Genet; 2009 Apr; 18(7):1368-75. PubMed ID: 19153072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis.
    Sato G; Shirai Y; Namba S; Edahiro R; Sonehara K; Hata T; Uemura M; ; Matsuda K; Doki Y; Eguchi H; Okada Y
    Nat Commun; 2023 Jun; 14(1):3671. PubMed ID: 37340002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.
    Yeager M; Deng Z; Boland J; Matthews C; Bacior J; Lonsberry V; Hutchinson A; Burdett LA; Qi L; Jacobs KB; Gonzalez-Bosquet J; Berndt SI; Hayes RB; Hoover RN; Thomas G; Hunter DJ; Dean M; Chanock SJ
    Hum Genet; 2009 Dec; 126(6):743-50. PubMed ID: 19644707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hints of hidden heritability in GWAS.
    Gibson G
    Nat Genet; 2010 Jul; 42(7):558-60. PubMed ID: 20581876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.
    Qian DC; Byun J; Han Y; Greene CS; Field JK; Hung RJ; Brhane Y; Mclaughlin JR; Fehringer G; Landi MT; Rosenberger A; Bickeböller H; Malhotra J; Risch A; Heinrich J; Hunter DJ; Henderson BE; Haiman CA; Schumacher FR; Eeles RA; Easton DF; Seminara D; Amos CI
    Hum Mol Genet; 2015 Dec; 24(25):7406-20. PubMed ID: 26483192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
    Lou H; Yeager M; Li H; Bosquet JG; Hayes RB; Orr N; Yu K; Hutchinson A; Jacobs KB; Kraft P; Wacholder S; Chatterjee N; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Ma J; Gaziano JM; Stampfer M; Schumacher FR; Giovannucci E; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Anderson SK; Tucker M; Hoover RN; Fraumeni JF; Thomas G; Hunter DJ; Dean M; Chanock SJ
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7933-8. PubMed ID: 19383797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
    Hunter DJ; Kraft P; Jacobs KB; Cox DG; Yeager M; Hankinson SE; Wacholder S; Wang Z; Welch R; Hutchinson A; Wang J; Yu K; Chatterjee N; Orr N; Willett WC; Colditz GA; Ziegler RG; Berg CD; Buys SS; McCarty CA; Feigelson HS; Calle EE; Thun MJ; Hayes RB; Tucker M; Gerhard DS; Fraumeni JF; Hoover RN; Thomas G; Chanock SJ
    Nat Genet; 2007 Jul; 39(7):870-4. PubMed ID: 17529973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A compendium of genome-wide associations for cancer: critical synopsis and reappraisal.
    Ioannidis JP; Castaldi P; Evangelou E
    J Natl Cancer Inst; 2010 Jun; 102(12):846-58. PubMed ID: 20505153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions.
    Lindström S; Wang L; Feng H; Majumdar A; Huo S; Macdonald J; Harrison T; Turman C; Chen H; Mancuso N; Bammler T; ; Gallinger S; Gruber SB; Gunter MJ; Le Marchand L; Moreno V; Offit K; ; De Vivo I; O'Mara TA; Spurdle AB; Tomlinson I; ; Fitzgerald R; Gharahkhani P; Gockel I; Jankowski J; Macgregor S; Schumacher J; Barnholtz-Sloan J; Bondy ML; Houlston RS; Jenkins RB; Melin B; Wrensch M; Brennan P; Christiani DC; Johansson M; Mckay J; Aldrich MC; Amos CI; Landi MT; Tardon A; ; Bishop DT; Demenais F; Goldstein AM; Iles MM; Kanetsky PA; Law MH; ; Amundadottir LT; Stolzenberg-Solomon R; Wolpin BM; ; Klein A; Petersen G; Risch H; ; Chanock SJ; Purdue MP; Scelo G; Pharoah P; Kar S; Hung RJ; Pasaniuc B; Kraft P
    J Natl Cancer Inst; 2023 Jun; 115(6):712-732. PubMed ID: 36929942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
    Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.